Hall 6 (Salle E&F, Floor 3)

08:00 - 09:00 BUSINESS MEETING
09:00 - 10:30

Young Investigator Award

Chair: Ina Michel-Behnke, Austria
Co-chair: Hiroyuki Yamagishi, Japan

O-031 Transcatheter Correction of Sinus Venosus Atrial Septal Defect: From Bench Testing to Clinical Success
Clement Batteux, France
O-032 Perinatal Hypoxia Aggravates Occlusive Pulmonary Vasculopathy In Rats Later In Life: Association With Epigenetic Changes,
Hironori Oshita, Japan
O-033 Kawasaki disease and the current SARS-CoV-2 pandemic: rare lessons from a cohort of more than 1000 Kawasaki patients in The Netherlands,
Stejara A Netea, Netherlands

O-034 The critical role of ER selective autophagy in response to Doxorubicin-induced myocardial injury,
Shun Nakagama, Japan
O-035 Percutaneous transhepatic periportal embolization of hepato-duodenal lymphatic fistulae as treatment for protein losing enteropathy after Fontan
Thomas Salaets, Belgium
O-036 Low- versus high-concentration intravenous immunoglobulin for children with Kawasaki disease in the acute phase,
Takanori Suzuki, Japan

10:30 - 11:00 BREAK
11:30 - 12:30


Cardiac Dysrhythmias and Electrophysiology & Genetics, Basic Science and Myocardial Disease

Chair: Alice Maltret, France
Co-chair: Nico Blom, Netherlands

P-217 AVNRT cryoablation in children < 26 Kg: efficacy and safety of electrophysiologically guided low voltage bridge strategy, Cristina Raimondo, Italy

P-248 Clinical characteristics and mid-term follow-up findings in children with isolated complete heart block: A single-center ten-year experience, Yakup Ergul, Turkey

P-254 Clinical course and electrophysiological characteristics of permanent junctional reciprocating tachycardia in children: ten years experience, Yakup Ergul, Turkey

P-207 Two broken pacemaker cans in one patient, Anna Cavigelli Brunner, Switzerland

P-247 Epicardial device migration in children – a rare but important complication, Tomasz Marcin Ksiazczyk, Poland

P-225 Catheter ablation of accessory pathways in children and patients with congenital heart disease: Predictors of outcome, John Papagiannis, Greece

P-257 Cardioneuroablation in a pediatric patient with Type IIb cardioinhibitory vasovagal syncope and functional advanced AV block, Yakup Ergül, Turkey

P-476 Clinical symptoms in children with genetic aortopathy and their response to medical therapy – A monocentric analysis over more than one decade, Jakob Olfe, Germany

P-487 Induced pluripotent stem cell-derived Chagas disease model highlights the role of cardiomyocytes as sentinels of the host-parasite interaction, Yu Nakagama, Japan

P-472 Homozygous Genetic Variant in Desmin Causes Severe Inflammatory Cardiomyopathy, Franziska Seidel, Germany

P-479 Arrhythmia and impaired myocardial function in Heritable Thoracic Aortic Disease: an international retrospective cohort study, Laura Muiño Mosquera, Belgium

P-474 Concerns about safety of growth hormone therapy in Noonan syndrome and other RASopathies: risk of triggering or worsening hypertrophic cardiomyopathy, Ingegerd Östman Smith, Sweden

12:30 - 14:00

Cardiac Dysrhythmias and Electrophysiology

Chair: Christian Balmer, Switzerland
Co-chair: Maria Cecilia Gonzalez, UK

O-061 Electrocardiographic and electrophysiological characteristics of fasciculoventricular fibers in children: Single-center 8-years experiencei
Yakup Ergul, Turkey
O-062 Assessment in a geographical cohort of PRIMaCY performance for risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy,
Eva Fernlund, Sweden
O-063 Arrhythmogenic cardiomyopathy in childhood,
Marit Kristine Smedsrud, Norway

O-064 Electrophysiologic characteristics and catheter ablation results of fascicular ventricular tachycardia in children,
Alper Güzeltaş, Turkey
O-065 Retrospective single-centre study of paediatric catheter ablation in the era of 3D navigation and mapping,
Jiri Houda, Czech Republic
O-066 Long-term fate of an unselected cohort of congenital long QT syndrome patients diagnosed in childhood,
Terezia Tavacova, Czech Republic

14:00 - 15:30

Fetal cardiovascular magnetic resonance imaging for prenatal diagnosis of complex congenital heart defects

Chair: Margarita Bartsota, Cyprus
Co-chair: Alexander Kovacevic,Germany

Feasibility of non-gated dynamic fetal cardiac MRI for identification of fetal cardiovascular anatomy,
Emanuela Valsangiacomo, Switzerland
Explanation of physics, technique of the MR conditional DUS gating device,
Fabian Kording, Germany
Fetal MRI – from research to clinical practice,
David Lloyd, UK

Utility of fetal CMR for prenatal diagnosis of complex congenital heart defects,
Katrin Fricke, Sweden

15:30 - 16:00


16:00 - 17:30

Artificial Inteligence and Cardiac Intensive Care

Chair: Nicole Sekarski, Switzerland
Co-chair: TBA

Artificial intelligence in the Cardiac Intensive Care,
Patricia Garcia Cañadilla, Spain
How to use Data to improve Patient Outcomes,
Sarah Tabbutt, United States
Remote Telemonitoring in the Cardiac Intensive Care,
Ricardo Munoz, United States
High Value Care Approach for patients with Congenital Heart Disease,
Joan Sanchez-de-Toledo, Spain